These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 15353134

  • 1. Allogeneic peripheral blood stem cell transplantation in patients with haematological malignancies.
    Shamsi TS, Irfan M, Ansari SH, Farzana T, Khalid MZ, Panjwani VK, Baig MI, Shakoor N.
    J Coll Physicians Surg Pak; 2004 Sep; 14(9):522-6. PubMed ID: 15353134
    [Abstract] [Full Text] [Related]

  • 2. Peripheral blood stem cell transplantation in children with beta-thalassemia major.
    Farzana T, Shamshi TS, Irfan M, Ansari SH, Baig MI, Shakoor N.
    J Coll Physicians Surg Pak; 2003 Apr; 13(4):204-6. PubMed ID: 12718774
    [Abstract] [Full Text] [Related]

  • 3. Allogeneic peripheral blood stem cell transplantation in patients with early-phase hematologic malignancy: a retrospective comparison of short-term outcome with bone marrow transplantation.
    Lemoli RM, Bandini G, Leopardi G, Rosti G, Bonini A, Fortuna A, Rondelli D, Mangianti S, Motta MR, Rizzi S, Tassi C, Cavo M, Remiddi C, Curti A, Conte R, Tura S.
    Haematologica; 1998 Jan; 83(1):48-55. PubMed ID: 9542323
    [Abstract] [Full Text] [Related]

  • 4. Similar survival following HLA-identical sibling transplantation for standard indication in children with haematologic malignancies: a single center comparison of mobilized peripheral blood stem cell with bone marrow transplantation.
    Meisel R, Enczmann J, Balzer S, Bernbeck B, Kramm C, Schönberger S, Sinha K, Tröger A, Wernet P, Göbel U, Laws HJ, Dilloo D.
    Klin Padiatr; 2005 Jan; 217(3):135-41. PubMed ID: 15858704
    [Abstract] [Full Text] [Related]

  • 5. Factors influencing the haematological recovery after allogeneic bone marrow transplantation in leukaemia patients treated with methotrexate-containing GVHD prophylaxis: a single-centre experience.
    Hassan HT, Krog C, Stockschläder M, Schleimer B, Zeller W, Krüger W, Erttmann R, Zander AR.
    Anticancer Res; 1997 Jan; 17(1B):589-99. PubMed ID: 9066585
    [Abstract] [Full Text] [Related]

  • 6. [A pilot study of G-CSF mobilized allogeneic bone marrow cells plus peripheral blood stem cells transplantation for malignant hematological diseases].
    Chen Y, Huang X, Xu L, Liu D, Zhang Y, Ren H, Guo N, Lu D.
    Zhonghua Yi Xue Za Zhi; 2002 Oct 10; 82(19):1306-9. PubMed ID: 12509932
    [Abstract] [Full Text] [Related]

  • 7. [Allogeneic peripheral blood stem cell transplantation in the treatment of hematologic malignancies].
    Wang F, Huang X, Ren H, Zhang Y, Xu L, Chen Y, Liu K, Guo N, Lu D.
    Zhonghua Xue Ye Xue Za Zhi; 2002 Aug 10; 23(8):403-6. PubMed ID: 12411042
    [Abstract] [Full Text] [Related]

  • 8. Cytokine-mobilized allogeneic peripheral blood stem cell transplants in children result in rapid engraftment and a high incidence of chronic GVHD.
    Levine JE, Wiley J, Kletzel M, Yanik G, Hutchinson RJ, Koehler M, Neudorf S.
    Bone Marrow Transplant; 2000 Jan 10; 25(1):13-8. PubMed ID: 10654008
    [Abstract] [Full Text] [Related]

  • 9. Post-transplant infections: single center experience from the developing world.
    Ullah K, Raza S, Ahmed P, Chaudhry QU, Satti TM, Ahmed S, Mirza SH, Akhtar F, Kamal K, Akhtar FM.
    Int J Infect Dis; 2008 Mar 10; 12(2):203-14. PubMed ID: 17920999
    [Abstract] [Full Text] [Related]

  • 10. Hematopoietic stem cell transplantation for high-risk adult patients with severe aplastic anemia; reduction of graft failure by enhancing stem cell dose.
    Min CK, Kim DW, Lee JW, Han CW, Min WS, Kim CC.
    Haematologica; 2001 Mar 10; 86(3):303-10. PubMed ID: 11255278
    [Abstract] [Full Text] [Related]

  • 11. [Allogeneic hematopoietic transplantation with stem cells extracted from peripheral blood].
    Kusminsky G, Foncuberta MC, Aversa L, Drelichman G, Freigeiro D, Burgos R, Irrazabal C, Gonzalez G, Dictar M, Niborski R, Kohan A, Sanchez Avalos JC.
    Medicina (B Aires); 2000 Mar 10; 60(2):179-87. PubMed ID: 10962806
    [Abstract] [Full Text] [Related]

  • 12. [Allogeneic peripheral blood stem cell transplantation for high-risk leukemia].
    Huang X, Wang F, Guo N.
    Zhonghua Yi Xue Za Zhi; 2001 Nov 25; 81(22):1348-51. PubMed ID: 11930625
    [Abstract] [Full Text] [Related]

  • 13. Sirolimus and tacrolimus without methotrexate as graft-versus-host disease prophylaxis after matched related donor peripheral blood stem cell transplantation.
    Cutler C, Kim HT, Hochberg E, Ho V, Alyea E, Lee SJ, Fisher DC, Miklos D, Levin J, Sonis S, Soiffer RJ, Antin JH.
    Biol Blood Marrow Transplant; 2004 May 25; 10(5):328-36. PubMed ID: 15111932
    [Abstract] [Full Text] [Related]

  • 14. Allogeneic blood stem cell transplantation in chronic myeloid leukaemia-chronic phase following conditioning with busulphan and cyclophosphamide: a follow up report.
    Saikia TK, Parikh PM, Tawde S, Amare-Kadam PS, Rajadhyaksha S, Chhaya S.
    Natl Med J India; 2004 May 25; 17(2):71-3. PubMed ID: 15141598
    [Abstract] [Full Text] [Related]

  • 15. G-CSF given after haematopoietic stem cell transplantation using HLA-identical sibling donors is associated to a higher incidence of acute GVHD II-IV.
    Remberger M, Naseh N, Aschan J, Barkholt L, LeBlanc K, Svennberg P, Ringdén O.
    Bone Marrow Transplant; 2003 Jul 25; 32(2):217-23. PubMed ID: 12838288
    [Abstract] [Full Text] [Related]

  • 16. Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients.
    Lazarus HM, Koc ON, Devine SM, Curtin P, Maziarz RT, Holland HK, Shpall EJ, McCarthy P, Atkinson K, Cooper BW, Gerson SL, Laughlin MJ, Loberiza FR, Moseley AB, Bacigalupo A.
    Biol Blood Marrow Transplant; 2005 May 25; 11(5):389-98. PubMed ID: 15846293
    [Abstract] [Full Text] [Related]

  • 17. Allogeneic peripheral blood stem cell transplantation for leukemia.
    Zhu K, Xu Y, Wu D, Xu X, Huang L.
    Chin Med J (Engl); 2001 May 25; 114(5):493-6. PubMed ID: 11780411
    [Abstract] [Full Text] [Related]

  • 18. Impact of postgrafting immunosuppressive regimens on nonrelapse mortality and survival after nonmyeloablative allogeneic hematopoietic stem cell transplant using the fludarabine and low-dose total-body irradiation 200-cGy.
    Koh LP, Chen CS, Tai BC, Hwang WY, Tan LK, Ng HY, Linn YC, Koh MB, Goh YT, Tan B, Lim S, Lee YM, Tan KW, Liu TC, Ng HJ, Loh YS, Mow BM, Tan DC, Tan PH.
    Biol Blood Marrow Transplant; 2007 Jul 25; 13(7):790-805. PubMed ID: 17580257
    [Abstract] [Full Text] [Related]

  • 19. Treatment with granulocyte colony-stimulating factor after allogeneic bone marrow transplantation for acute leukemia increases the risk of graft-versus-host disease and death: a study from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
    Ringdén O, Labopin M, Gorin NC, Le Blanc K, Rocha V, Gluckman E, Reiffers J, Arcese W, Vossen JM, Jouet JP, Cordonnier C, Frassoni F.
    J Clin Oncol; 2004 Feb 01; 22(3):416-23. PubMed ID: 14691124
    [Abstract] [Full Text] [Related]

  • 20. Unrelated umbilical cord blood transplantation for adults with haematological malignancies: results from a single Australian centre.
    Bradstock KF, Hertzberg MS, Kerridge IH, Svennilson J, McGurgan M, Huang G, Antonenas V, Gottlieb DJ.
    Intern Med J; 2006 Jun 01; 36(6):355-61. PubMed ID: 16732860
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.